결핵 진료지침
27. predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country. BMC Nephrol 2017;18:88.
28. Kim SH, Lee SO, Park IA, Kim SM, Park SJ, Yun SC, et al. Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-γ -releasing assay: an exploratory randomized controlled trial. J Antimicrob Chemother 2015;70:1567–72.
29. Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 2007;34:706–11.
30. Kim ES, Song GA, Cho KB, Park KS, Kim KO, Jang BI, et al. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents. World J Gastroenterol 2015;21:3308–16.
31. Wallis RS. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 2008;8:601–11.
32. Shimouchi A, Ozasa K. The incidence rate of active pulmonary tuberculosis among adult population with fibrotic lesions. Kekkaku 2003;78:5–13.
33. Linh NN, Marks GB, Crawford AB. Radiographic predictors of subsequent reactivation of tuberculosis. Int J Tuberc Lung Dis 2007;11:1136–42.
34. Jeong YJ, Yoon S, Koo HK, Lim HJ, Lee JS, Lee SM, et al. Positive tuberculin skin test or interferon-gamma release assay in patients with radiographic lesion suggesting old healed tuberculosis. J Korean Med Sci 2012;27:761–6.
35. Jeong YJ, Paeng JC, Nam HY, Lee JS, Lee SM, Yoo CG, et al. (18)F-FDG positron-emission tomography/computed tomography findings of radiographic lesions suggesting old healed tuberculosis. J Korean Med Sci 2014;29:386–91.
36. Cagatay T, Aydin M, Sunmez S, Cagatay P, Gulbaran Z, Gul A, et al. Follow-up results of 702 patients receiving tumor necrosis factor-α antagonists and evaluation of risk of tuberculosis. Rheumatol Int 2010;30:1459–63.

320 Ⅷ. 잠복결핵감염